• Viralytics Ltd., of Sydney, appointed Keith Flaherty to its scientific advisory board. Flaherty is director of the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital Cancer Center and associate professor of medicine at Harvard Medical School.